CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy (Q46523211)
Jump to navigation
Jump to search
scientific article published on 23 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy |
scientific article published on 23 June 2008 |
Statements
1 reference
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy (English)
1 reference
1 reference
D Ennishi
1 reference
M Yokoyama
1 reference
H Asai
1 reference
Y Mishima
1 reference
Y Terui
1 reference
S Takahashi
1 reference
H Komatsu
1 reference
K Ikeda
1 reference
M Yamaguchi
1 reference
R Suzuki
1 reference
M Tanimoto
1 reference
K Hatake
1 reference
23 June 2008
1 reference
1 reference
19
1 reference
11
1 reference
1921-1926
1 reference
Identifiers
1 reference
1 reference